← FDA DRUG APPROVALS

FDA ANDA · ANDA206890

ILOPERIDONE

Sponsor: LUPIN

APPLICATION
ANDA206890
TYPE
ANDA
ORIGINAL APPROVAL
2022-05-05
LATEST ACTION
2022-05-05
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

ILOPERIDONEDiscontinued
ILOPERIDONE 1MG · TABLET · ORAL
ILOPERIDONEDiscontinued
ILOPERIDONE 10MG · TABLET · ORAL
ILOPERIDONEDiscontinued
ILOPERIDONE 6MG · TABLET · ORAL
ILOPERIDONEDiscontinued
ILOPERIDONE 2MG · TABLET · ORAL
ILOPERIDONEDiscontinued
ILOPERIDONE 12MG · TABLET · ORAL
ILOPERIDONEDiscontinued
ILOPERIDONE 8MG · TABLET · ORAL
ILOPERIDONEDiscontinued
ILOPERIDONE 4MG · TABLET · ORAL

Approval history

2022-05-05UNKNOWN · Original · standardReviewAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →